Oligopeptides
"Oligopeptides" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Peptides composed of between two and twelve amino acids.
Descriptor ID |
D009842
|
MeSH Number(s) |
D12.644.456
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Oligopeptides".
Below are MeSH descriptors whose meaning is more specific than "Oligopeptides".
This graph shows the total number of publications written about "Oligopeptides" by people in this website by year, and whether "Oligopeptides" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 1 | 1 | 2 | 1996 | 1 | 1 | 2 | 1998 | 1 | 3 | 4 | 1999 | 1 | 5 | 6 | 2000 | 5 | 3 | 8 | 2001 | 2 | 2 | 4 | 2002 | 3 | 2 | 5 | 2003 | 2 | 5 | 7 | 2004 | 4 | 3 | 7 | 2005 | 3 | 3 | 6 | 2006 | 8 | 3 | 11 | 2007 | 5 | 5 | 10 | 2008 | 7 | 1 | 8 | 2009 | 6 | 7 | 13 | 2010 | 4 | 3 | 7 | 2011 | 3 | 7 | 10 | 2012 | 9 | 3 | 12 | 2013 | 10 | 6 | 16 | 2014 | 8 | 3 | 11 | 2015 | 5 | 3 | 8 | 2016 | 1 | 4 | 5 | 2017 | 1 | 1 | 2 | 2018 | 6 | 1 | 7 | 2019 | 3 | 3 | 6 | 2020 | 3 | 0 | 3 | 2021 | 1 | 1 | 2 | 2022 | 1 | 4 | 5 | 2023 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Oligopeptides" by people in Profiles.
-
Self WH, Shotwell MS, Gibbs KW, de Wit M, Files DC, Harkins M, Hudock KM, Merck LH, Moskowitz A, Apodaca KD, Barksdale A, Safdar B, Javaheri A, Sturek JM, Schrager H, Iovine N, Tiffany B, Douglas IS, Levitt J, Busse LW, Ginde AA, Brown SM, Hager DN, Boyle K, Duggal A, Khan A, Lanspa M, Chen P, Puskarich M, Vonderhaar D, Venkateshaiah L, Gentile N, Rosenberg Y, Troendle J, Bistran-Hall AJ, DeClercq J, Lavieri R, Joly MM, Orr M, Pulley J, Rice TW, Schildcrout JS, Semler MW, Wang L, Bernard GR, Collins SP. Renin-Angiotensin System Modulation With Synthetic Angiotensin (1-7) and Angiotensin II Type 1 Receptor-Biased Ligand in Adults With COVID-19: Two Randomized Clinical Trials. JAMA. 2023 04 11; 329(14):1170-1182.
-
Ediae GU, Lemire G, Chisholm C, Hartley T, Eaton A, Osmond M, Rojas SK, Huang L, Gillespie M, Sawyer SL, Boycott KM. The implementation of an enhanced clinical model to improve the diagnostic yield of exome sequencing for patients with a rare genetic disease: A Canadian experience. Am J Med Genet A. 2023 02; 191(2):338-347.
-
Navarro-Becerra JA, Castillo JI, Di Ruzza F, Borden MA. Monodispersity Increases Adhesion Efficiency and Specificity for Ultrasound-Targeted Microbubbles. ACS Biomater Sci Eng. 2023 02 13; 9(2):991-1001.
-
Zhang Y, Towers CG, Singh UK, Liu J, H?kansson M, Logan DT, Donini O, Kutateladze TG. Dusquetide modulates innate immune response through binding to p62. Structure. 2022 08 04; 30(8):1055-1061.e7.
-
Borovsky D, Roug? P, Shatters RG. The Ribosome Is the Ultimate Receptor for Trypsin Modulating Oostatic Factor (TMOF). Biomolecules. 2022 04 14; 12(4).
-
Wu G, Li X, Seo H, McLendon BA, Kramer AC, Bazer FW, Johnson GA. Osteopontin (OPN)/Secreted Phosphoprotein 1 (SPP1) Binds Integrins to Activate Transport of Ions Across the Porcine Placenta. Front Biosci (Landmark Ed). 2022 04 01; 27(4):117.
-
Bennett R, Chan H, Henderson R, Merriman E, Hanna M, Elinder-Camburn A, Simpson D. The addition of lopinavir-ritonavir to carfilzomib-based triplets can induce meaningful clinical response in carfilzomib-refractory myeloma patients: a single-center experience. Leuk Lymphoma. 2022 07; 63(7):1738-1741.
-
Cantrell MS, Wall JD, Pu X, Turner M, Woodbury L, Fujise K, McDougal OM, Warner LR. Expression and purification of a cleavable recombinant fortilin from Escherichia coli for structure activity studies. Protein Expr Purif. 2022 01; 189:105989.
-
Forsberg PA, Rossi AC, Boyer A, Pearse RN, Pekle KA, Jayabalan D, Lakritz S, Flicker K, Ribadeneyra D, Liotta B, Ely S, Boussi L, Allan JN, Coleman M, Niesvizky R, Mark TM. Carfilzomib and dexamethasone induction with lenalidomide, clarithromycin and dexamethasone consolidation and lenalidomide maintenance for newly diagnosed multiple myeloma. Am J Hematol. 2021 12 01; 96(12):1554-1562.
-
Sherbenou D, Stalker M, Forsberg P, Mark TM. Sustained Response to Selinexor-Based Therapy for Triple-Class Refractory Multiple Myeloma with Early Relapse After Allogeneic Stem Cell Transplantation. Clin Lymphoma Myeloma Leuk. 2021 07; 21(7):e630-e634.
|
People People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|